MEDIFAST INC overview

Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTA VIA®, will announce financial results for the fourth quarter and full year ended December 31, 2024 on Tuesday, February 18, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The...

Medifast (NYSE:MED), the health and wellness company known for its habit based and coach-guided lifestyle solution OPTA VIA, today announced OPTAVIA ASCEND — a new product line of high-protein, fiber-rich mini meals as well as a daily nutrient pack. These products are featured in two new science-backed nutrition plans designed for people on GLP-1 medications and those looking for help to keep weight off. The mini meals provide essential nutrients to promote muscle health, digestive health and...

Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTA VIA® , today shared findings from a recent independent survey. Commissioned by Medifast and conducted by the third-party market research firm Talker Research, the goal of the survey was to better understand American perceptions of weight loss medications and their role in health journeys, while also identifying areas where further support is necessary. The survey of 2,000...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE: MED ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Medifast reported its quarterly earnings on April 29, 2024. The Company's adjusted earnings per share of $0.66...

LOS ANGELES, CA / ACCESSWIRE / April 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Medifast reported its quarterly earnings on April 29, 2024. The...

Medifast Named as One of the "Best Companies To Work For" by U.S. News & World Report Company recognized as one of the top 20% best employers in the food and drink industry for 2023-2024 PR Newswire BALTIMORE, Oct. 5, 2023 BALTIMORE , Oct. 5, 2023 /PRNewswire/ -- Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution OPTA VIA ® , today announced that it has been recognized in the 2023-2024 rankings by U.S. News & World Report as one...

OPTAVIA ACTIVE™ Now Available New line of premium exercise supplements and protein powders are designed to address age-related muscle mass decline and support muscle health Current products include Informed Sport certified OPTAVIA ACTIVE Essential Amino Acid (EAA) Blend and Whey Protein, both made with no colors, flavors or sweeteners from artificial sources PR Newswire BALTIMORE, Sept. 13, 2023 BALTIMORE , Sept. 13, 2023 /PRNewswire/ -- Medifast (NYSE: MED), the health and wellness company...

Medifast Announces Quarterly Dividend PR Newswire BALTIMORE, Sept. 7, 2023 BALTIMORE , Sept. 7, 2023 /PRNewswire/ -- Medifast (NYSE: MED), the company behind the health and wellness community, OPTA VIA® , today announced that its Board of Directors has declared a $1.65 quarterly cash dividend to its stockholders. The quarterly cash dividend of $1.65 per share is payable on November 7, 2023 , to stockholders of record as of the close of business on September 19, 2023 . Medifast expects to...